<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6958409\results\search\drugs\results.xml">
  <result pre="the clinic are Matrix 2 (M2) ion channel inhibitors, (e.g.," exact="amantadine" post="and rimantadine) and neuraminidase (NA) inhibitors (e.g., oseltamivir and"/>
  <result pre="inhibitors, (e.g., amantadine and rimantadine) and neuraminidase (NA) inhibitors (e.g.," exact="oseltamivir" post="and zanamivir) [6]. The emergence of resistant virus strains"/>
  <result pre="to be functional and could be inhibited upon addition of" exact="oseltamivir" post="and zanamivr [132], suggesting that the yeast-based system is"/>
  <result pre="M2 and compared the efficacy of the novel compounds to" exact="amantadine" post="which led to new lead compounds against M2 [134,135]."/>
  <result pre="found to have a more severe phenotype than females. Importantly," exact="amantadine" post="was shown to rescue the M2 phenotype, suggesting Drosophila"/>
  <result pre="intracellular reactive oxygen species (ROS) and had increased expression of" exact="nicotinamide" post="adenine dinucleotide phosphate oxidases (Nox) [256]. One particular Nox"/>
  <result pre="same patients. Using TVB024 prophylactically, the combination of TVB024 and" exact="oseltamivir" post="reduced viral shedding and this was more effective than"/>
  <result pre="oseltamivir reduced viral shedding and this was more effective than" exact="oseltamivir" post="alone in inhibiting epithelial infection. In addition, infected NHBE"/>
  <result pre="virus NS1 and Postsynaptic density protein-95 (PSD-95), and inhibition of" exact="nitric oxide" post="productionVirol. J.2011829810.1186/1743-422X-8-29821668967 152.WolffT.Oâ€™NeillR.E.PaleseP.Interaction cloning of NS1-I, a human protein"/>
 </snippets>
</snippetsTree>
